Delivery Order SPE2DB24D2012-SPE2DB24FBUSV
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Lantus Solostar 100 unit/ml 3ml insulin pens. The contract has a completion date of January 29, 2024 and a potential value of $2,338.88. This order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Lantus Solostar 100 unit/mL 3mL insulin pens. The $1,405.26 firm fixed-price contract has a completion date of September 25, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also holds a separate $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $2,958.74 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Lantus SoloStar 100 unit/mL 3mL insulin pens. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of Lantus Solostar 100 unit/ml 3ml insulin pens. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense, and has a firm fixed price ceiling value of $1,068.84. The contract is structured as a delivery order under a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Lantus Solostar 100 unit/mL 3mL insulin pens. The $1,029.22 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. (parent company of Amerisourcebergen Drug Corp) holds with the DLA Troop Support Medical through November 2026. This IDC serves as the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical supplier, for the delivery of Lantus Solostar insulin pens. The contract has a ceiling value of $1,768.16 and a completion date of May 22, 2024. It is a firm fixed price delivery order contract, without any set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $5,129.67 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The contract is for the supply of Lantus Solostar 100 unit/mL 3mL insulin pens, with a completion date of February 26, 2024. This delivery order is issued under a larger, single award indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued at...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $7,956.18 for the supply of Lantus Solostar 100 unit/ml 3ml insulin pens. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of March 26, 2024. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a delivery order valued at $1,267.16 for the supply of Lantus Solostar 100 unit/ml 3ml insulin pens. The contract was awarded on July 2, 2024 by the Defense Logistics Agency (DLA) Troop Support Medical, with a completion date of July 3, 2024. This order is issued under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 31, 2025. The...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of Lantus Solostar insulin pens. The firm fixed-price delivery order, valued at $1,108.36, has a period of performance through March 27, 2024. The contract was not set aside for any particular business category. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC)...
- SPE2DB24D2012Indefinite Delivery Contract
- SPE2DB24D2012-SPE2DB24FBUSVDelivery Order
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Lantus Solostar 100 unit/mL, 3mL insulin pens. The contract is a Delivery Order with a Firm Fixed Price of $2,484.48 and an ultimate completion date of April 18, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. This appears to be a task order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical products and medical supplies to support the Department of Defense's military treatment programs and facilities worldwide. The contract does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 4/17/24 |